| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |